KFF on Why Medicare's Aduhelm Coverage Decision Could Increase Pressure on Officials to Roll Back the Record Part B Premium Increase for 2022
January 18, 2022 - In a new Policy Watch, KFF experts explain why Medicare's preliminary decision to cover a new Alzheimer's drug only for a limited group of beneficiaries is likel…
